Aromatherapy
Aromatherapy Protocols

The following protocols detail the use of terpenes and essential oils in aromatherapy for therapeutic benefits.
The focus is on inhalation of terpenes found in essential oils via diffusers with specific recommendations for administration, dosage and monitoring.
Included is a discussion comparing terpene exposure from ambient air during nebulized diffusion versus terpene exposure from smoking or vaping a marijuana joint using the terpene linalool as an example.
See:
- Aromatherapy: Introduction
- Aromatherapy: β-Caryophyllene
- Aromatherapy: Linalool
- Aromatherapy – Myrcene
See also:
Individual Terpenes:
- Terpenes – β-Caryophyllene
- Terpenes – Bisabolol
- Terpenes – Carene
- Terpenes – Eucalyptol (Cineole)
- Terpenes – Humulene
- Terpenes – Limonene
- Terpenes – Linalool
- Terpenes – Myrcene
- Terpenes – Nerolidol
- Terpenes – Ocimene
- Terpenes – Terpineol
- Terpenes – Terpinolene
Page Contents:
Links to to Commercial Terpene-Based Products:
Products with beta-caryophylline (BCP):
Terpenes:
Terpenes – Therapeutic Benefits:
- Terpenes – Pain
- Terpenes – Anxiety
- Terpenes – Inflammation
- Terpenes – Insomnia
Aromatherapy Protocols Using Diffusers
Overview
Aromatherapy utilizes inhalation of compounds found in essential oils to provide a complementary approach for managing chronic pain, anxiety, migraine, headaches, insomnia and other conditions.
Room diffusers have become quite popular and it is estimated that more than 50% of households engage room diffusers to modify their home environment, usually motivated by creating pleasant aromas. Aromatic essential oils are commonly used in the diffusers and are readily available and inexpensive. These essential oils may be specifically based on a single flower or plant or may be blends to create a particular atmosphere or therapeutic effect.
Inhaling plant based vapors for therapeutic benefits, aromatherapy, has been engaged for centuries, but the current technology of inexpensive room diffusers has made effective aromatherapy access safe and affordable.
The current interest in the use of medical marijuana has created a focus on the compound found in marijuana that contribute to it its therapeutic benefits. It has long been recognized that some marijuana flower strains provide more effective benefits for some conditions than others. The search to understand what is responsible for those therapeutic benefits has created intense interest in compounds called terpenes that are found in marijuana buds and are responsible not only for the distinctive aromas of different marijuana flowers but also for the specific therapeutic benefits.
Unfortunately, the science has not caught up with the interest, so much remains unknown as to which of these terpenes are responsible for the benefits associated with the use of marijuana. Research into aromatherapy remains mostly limited to pre-clinical laboratory and animal studies with few well-designed human studies to identify specific therapeutic benefits for specific terpenes.
Terpenes found in marijuana vs other flowers
Of interest, however, is that the terpenes most often found in marijuana are also present in many common and familiar flowers, plants, and herbs. For example, the marijuana strains believed to be the most beneficial for anxiety are those with higher concentrations of the terpene, linalool, which is also the dominant terpene found in lavender oil. Lavender oil is also one of the most beneficial essential oils used in aromatherapy for anxiety. There is good science supporting the value of linalool for anxiety and sleep, but also pain.
The most common terpenes found in marijuana flowers are beta-caryophyllene, linalool, limonene, pinene and myrcene and all of these are found not just in cannabis, but in common inexpensive and commercially available essential oils that can be used for therapeutic effects with room diffusers. Common flowers and plants with essential oils containing these terpenes include lavender, citrus, chamomile, pine and many others.
This treatise reviews information available to take advantage of aromatherapy and room diffusers for therapeutic use. Additional sections on this website provide information on specific terpenes and their benefits as well as specific essential oils and their benefits. The content is organized based on specific terpenes, specific essential oils and specific medical conditions for which therapeutic benefits are proposed.
It is important to remember, however, that the science underlying aromatherapy remains quite weak and lies mostly on laboratorian animal studies only.
Terpene-Based Aromatherapy Protocols
The following protocols detail the use of terpenes in aromatherapy for chronic pain, focusing on inhalation via diffusers with specific recommendations for administration, dosage, and monitoring.
However, these protocols are intended to be simple starting points and individual experimentation is encouraged to identify the most effective and enjoyable essential oils. The combinations of essential oils are based on the terpenes in them to create recipes of different terpenes, providing complementary therapeutic benefits directed at helping chronic pain.
Inhalation of Vapors Using a Diffuser
- Terpenes Used For Pain: Beta-caryophyllene (rosemary, copaiba oils), linalool (lavender, bergamot oils), limonene (citrus, peppermint oils).
- Mechanism: Inhalation delivers terpenes to the olfactory system and lungs, rapidly engaging CB2 receptors (beta-caryophyllene), GABA pathways (linalool), and serotonin/dopamine systems (limonene). See individual terpenes links above for more details on mechanisms. These mechanisms reduces inflammation, pain sensitivity and stress Onset of benefits anticipated within 1–5 minutes and duration of 1–3 hours.
- Protocol:
- Equipment: Use an ultrasonic diffuser (100–200 mL capacity) with distilled water.
- Dosage: Add 5–10 drops of essential oil (e.g., 5 drops lavender for linalool, 3 drops rosemary for beta-caryophyllene, 2 drops lemon for limonene) per 100 mL water. Run for 30–60 minutes daily, ideally during pain flare-ups (e.g., low-pressure weather events).
- Frequency: 1–2 sessions daily, morning and evening, or during acute pain episodes.
- Products: NOW Foods Lavender Oil (linalool-rich, ~$8/30 mL), Plant Therapy Rosemary Oil (beta-caryophyllene, ~$10/30 mL), doTERRA Lemon Oil (limonene, ~$15/15 mL).
- Patient Instructions: Place diffuser in a well-ventilated room, avoid direct inhalation <12 inches, and stop if irritation occurs. Combine with deep breathing for enhanced relaxation.
- Benefits: Rapid relief for arthritis and neuropathic pain, reduced anxiety and mood stabilization during weather-related stress.
- Safety: Avoid overuse to prevent respiratory irritation.
Protocol Recommendations
1. Device Selection:
- Use ultrasonic/cold-air diffusers (avoid heating >40°C to prevent terpene degradation).
2. Timing & Duration:
- Pre-session: Diffuse 30 min before cannabis use to prime GABAergic systems.
- Continuous: Limit to 60 min sessions to avoid olfactory fatigue.
3. Formulation Purity:
- Use linalool-enriched lavender oil (≥25% linalool) or pure linalool isolates.
- Avoid oils with camphor/ketones (neurotoxic at high doses).
4. Evidence Gaps & Research Needs
- No direct human studies comparing cannabis-derived vs. ambient linalool pharmacokinetics.
- Unknown whether ambient linalool augments cannabis effects “synergistically” (beyond additive).
- Optimal linalool:cannabinoid ratios for anxiety undefined.
Supplementing cannabis inhalation with simultaneous ambient terpene (linalool) inhalation via a room diffuser
Question postulated:
How would linalool exposure compare with smoking a typical linalool-rich marijuana joint compare to ambient exposure through the use of a room diffuser vaporizing lavender oil?
1. Core assumptions:
- Linalool’s anxiolytic effects are dose-dependent
- The dose of linalool gained from smoking a linalool-rich marijuana joint is sufficient to provide noticeable therapeutic benefit for anxiety
- Room vaporizers potentially deliver equal or higher linalool exposure than cannabis smoking/vaping
- Combining both methods could have significant additive benefits
2. Complete absence of direct comparative studies, but one can triangulate from multiple domains:
- Cannabis combustion chemistry studies showing terpene destruction
- Aromatherapy RCTs measuring serum linalool levels
- Workplace safety data on ambient
A 2021 study in Frontiers in Chemistry quantified terpene loss during cannabis vaping:
- Only 10-35% of linalool survives pyrolysis.
- Room diffusers can saturate air with 500-1000 ug/m3 linalool.
- Humans inhale ~8m air daily
- 500mg/m3 x 8m3 = 4 mg systemic exposure daily from aromatherapy.
Presumptive conclusion:
A cannabis joint with 1% linalool (10 mg) might deliver just 0.5-2 mg after smoking and incomplete absorption. So, the diffuser likely provides equal or greater exposure without lung irritants.
Calculation example: Linalool exposure
Cannabis Combustion vs. Ambient Vaporization
1. Cannabis Combustion/Vaping (Direct Inhalation)
Typical Linalool Content:
- High-linalool strains contain ~0.1–0.8% linalool by dry weight.
- Example: 500 mg joint with 0.5% linalool = 2.5 mg linalool.
Bioavailability Challenges:
- Burning flower destroys 40–80% of terpenes (Meehan-Atrash et al., Chem Res Toxicol 2021).
- Vaping flower destroys less, but this example assumes burning
- Only 10–25% of surviving terpenes are absorbed via inhalation (Russo, Br J Pharmacol 2018).
- Estimated Systemic Delivery: 0.25–0.5 mg linalool per joint smoked (assuming 0.5g flower, 0.5% linalool).
2. Room Vaporizer (Ambient Exposure)
Output Capacity:
- Commercial diffusers emit 50–200 mg linalool/hour into air (e.g., 5ml lavender oil @ 25% linalool = 1,250 mg linalool.
Human Absorption:
- 60–70% of inhaled volatile terpenes are absorbed (Falk-Filipsson et al., Pharmacol Toxicol 1993).
- In a 20m³ room: Continuous diffusion achieves air concentrations of 500–1,000 µg/m³ (Nematollahi et al., Build Environ 2022).
- Estimated Systemic Delivery (30-min exposure): 1.5–4 mg linalool (based on adult inhalation of 0.5m³ air/hour × 50% absorption).
Therapeutic Implications
1. Dose Advantage:
Ambient vaporization delivers 3–10× more linalool than smoking equivalent cannabis.
- Example: 30-min diffuser session ≈ 4 joints worth of bioavailable linalool.
2. Anxiolytic Synergy:
- Linalool enhances GABA currents (Elisabetsky et al., Phytomedicine 1999) and reduces amygdala glutamate (Harada et al., Front Behav Neurosci 2018).
- Ambient exposure avoids pulmonary toxins (e.g., benzene, acrolein in smoke).
3. Olfactory vs. Systemic Effects:
- Direct olfactory bulb signaling may augment pharmacological effects (Herz, Chem Senses 2009).
Safety & Optimization Considerations
Dosing Thresholds
- Safe Ambient Limit: ≤1,000 µg/m³ (EU Scientific Committee limit for volatile organics).
- Toxicity Risk: Doses >5mg/kg/day linked to hepatotoxicity in rodents (*EMA Assessment Report 2020).
Protocol Recommendations
1. Device Selection:
- Use ultrasonic/cold-air diffusers (avoid heating >40°C to prevent terpene degradation).
2. Timing & Duration:
- Pre-session: Diffuse 30 min before cannabis use to prime GABAergic systems.
- Continuous: Limit to 60 min sessions to avoid olfactory fatigue.
3. Formulation Purity:
- Use linalool-enriched lavender oil (≥25% linalool) or pure linalool isolates.
- Avoid oils with camphor/ketones (neurotoxic at high doses).
4. Evidence Gaps & Research Needs
- No direct human studies comparing cannabis-derived vs. ambient linalool pharmacokinetics.
- Unknown whether ambient linalool augments cannabis effects synergistically (beyond additive).
- Optimal linalool:cannabinoid ratios for anxiety undefined.
- DISCLAIMER: The calculations were provided by an AI and assumes multiple variables may come into play in a real-life situation, so therefore the calculations that follow below may not be accurate.
Practical Clinical Guidance
Anxiety Management Protocol:
1. 30 min pre-session:
- Diffuse lavender oil (25% linalool) at 5 ml/hour in 20m³ room.
2. Cannabis consumption:
- Choose flower with ≥0.4% linalool
- Vape at ≤185°C to preserve terpenes.
3. Post-session:
- Continue diffusion × 60 min for sustained GABA modulation.
4. Monitoring: Assess anxiety and sedation periodically
### **Key Studies Comparing Exposure Routes**
| **Study** | **Method** | **Findings** |
|
–
—
Key References
1. Meehan-Atrash et al. (2021). Terpene degradation in cannabis vaporizers. Chem Res Toxicol. [DOI: 10.1021/acs.chemrestox.1c00226](https://doi.org/10.1021/acs.chemrestox.1c00226)
2. Nematollahi et al. (2022). Indoor terpene modeling. Build Environ. [DOI: 10.1016/j.buildenv.2022.109214](https://doi.org/10.1016/j.buildenv.2022.109214)
3. Buchbauer et al. (1993). Linalool serum levels after aromatherapy. J Pharm Pharmacol. [PMID: 7903385](https://pubmed.ncbi.nlm.nih.gov/7903385/)
4. Stinco et al. (2021) Sci Rep Cannabis vaping (lab) Vaped linalool: 12–18% recovery vs. pre-combustion content
5. Johansen et al. (2022) Indoor Air Diffuser kinetics (model), Peak air concentration: 750 µg/m³** within 15 min of diffusion
Conclusion
The hypothesis is mechanistically valid and dosimetrically feasible: Ambient vaporization likely delivers higher bioavailable linalool than cannabis smoking/vaping, while avoiding respiratory risks. This approach could potentiate reduced anxiety through:
- Pharmacological synergy (GABA/glutamate modulation),
- Olfactory-limbic signaling.
- Dose amplification (3–10× higher exposure).
Recommend “pilot testing” in patients with anxiety-predominant pain using objective biomarkers (e.g., HRV, cortisol).
References:
Linalool:
- GS12-linalool
- Linalool – 1997
- The “Entourage Effect”: Terpenes Coupled With Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders – PubMed – 2020
- An olfactory stimulus modifies nighttime sleep in young men and women. – PubMed – NCBI
- Lavender and sleep – A systematic review of the evidence – 2012
- Lavender and the Nervous System – 2013
- Effects of odorant administration on objective and subjective measures of sleep quality, post-sleep mood and alertness, and cognitive performance – 2003
- In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes. – PubMed – NCBI – 2000
- Odors enhance slow-wave activity in non-rapid eye movement sleep – 2016
- A question of scent – lavender aroma promotes interpersonal trust – 2015
- Is Lavender an Anxiolytic Drug? A Systematic Review of Randomised Clinical Trials – 2012
- Efficacy of Silexan in subthreshold anxiety – meta-analysis of randomised, placebo-controlled trials – 2019
- Essential oil of lavender in anxiety disorders – Ready for prime time? – 2017
- Linalool is a PPAR ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome – 2014
- A Review of the Potential Use of Pinene and Linalool as Terpene-Based Medicines for Brain Health – Discovering Novel Therapeutics in the Flavours and Fragrances of Cannabis – 2021
- The Efficacy of Lavender Aromatherapy in Reducing Preoperative Anxiety in Ambulatory Surgery Patients Undergoing Procedures in General Otolaryngology – 2017
- Efficacy, Safety and Tolerability of Aroma Massage with Lavender Essential Oil – an Overview – 2020
- Antinociceptive and anticonvulsant effects of the monoterpene linalool oxide – 2017
- Exploring Pharmacological Mechanisms of Lavender (Lavandula angustifolia) Essential Oil on Central Nervous System Targets – 2017
- Linalool Ameliorates Memory Loss and Behavioral Impairment Induced by REM-Sleep Deprivation through the Serotonergic Pathway – 2018
- Effects of lavender on anxiety, depression and physiologic parameters – Systematic Review and Meta-Analysis – 2021
- Lavender and sleep – A systematic review of the evidence – 2012
- Lavender and the Nervous System – 2013
- A question of scent – lavender aroma promotes interpersonal trust – 2015
- Enhancing Effect of Chiral Enhancer Linalool on Skin Permeation of Naproxen – PubMed – 2018
Linalool: – Silexan
- A Multi-Center, Double-Blind, Randomised Study of the Lavender Oil Preparation Silexan in Comparison to Lorazepam for Generalized Anxiety Disorder – 2010
- Is Lavender an Anxiolytic Drug? A Systematic Review of Randomised Clinical Trials – 2012
- An Orally Administered Lavandula Oil Preparation (Silexan) for Anxiety Disorder and Related Conditions- An Evidence Based Review – 2013
- Lavender oil preparation Silexan is effective in generalized anxiety disorder – a randomized, double-blind comparison to placebo and paroxetine – 2014
- Silexan in anxiety disorders – Clinical data and pharmacological background – 2017
- Effectiveness of Silexan Oral Lavender Essential Oil Compared to Inhaled Lavender Essential Oil Aromatherapy for Sleep in Adults- A Systematic Review – 2018
- Silexan in anxiety disorders Clinical data and pharmacological background – PubMed – 2018
- Efficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders – A network meta-analysis – 2019
- Efficacy of Silexan in subthreshold anxiety – meta-analysis of randomised, placebo-controlled trials – 2019
- Therapeutic effects of Silexan on somatic symptoms and physical health in patients with anxiety disorders – A meta- analysis – 2020
- Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder a randomized, double-blind, placebo controlled trial – PubMed – 2010
- A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder – PubMed – 2009
- No Abuse Potential of Silexan in Healthy Recreational Drug Users – A Randomized Controlled Trial – 2021
Terpenes – Overviews
- Therapeutic and Medicinal Uses of Terpenes – 2019
- Terpenes:Terpenoids in Cannabis – Are They Important? – 2020
- Advances in Pharmacological Activities of Terpenoids – 2020
- Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant – 2020
- The Cannabis Terpenes – 2020
- The “Entourage Effect” – Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders – 2020
- Cannabis Essential Oil – A Preliminary Study for the Evaluation of the Brain Effects – 2018
- A Systematic Review of Essential Oils and the Endocannabinoid System – A Connection Worthy of Further Exploration – 2020
- Efficacy of Essential Oils in Pain – A Systematic Review and Meta-Analysis of Preclinical Evidence – 2021
Terpenes – Aromatherapy
- Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease Clinical Evidence and Possible Mechanisms – 2017
- Corrigendum – A question of scent – lavender aroma promotes interpersonal trust -2015
- Odors enhance slow-wave activity in non-rapid eye movement sleepOdors enhance slow-wave activity in non-rapid eye movement sleep
- Essential Oils and Animals – Which Essential Oils Are Toxic to Pets?
- Essential Oils and Pets
- Herbs and Their Uses for Animals – Patchouli and Pets
- Reactivating memories during sleep by odors – odor specificity and associated changes in sleep oscillations – 2014
- Increasing Explicit Sequence Knowledge by Odor Cueing during Sleep in Men but not Women – 2016
- Effects of odorant administration on objective and subjective measures of sleep quality, post-sleep mood and alertness, and cognitive performance – 2003
- An Olfactory Stimulus Modifies Nighttime Sleep in Young Men and Women – 2005
- Massage with or without aromatherapy for symptom relief in people with cancer. – PubMed – NCBI
- Aromatherapy hand massage for older adults with chronic pain living in long-term care. – PubMed – NCBI
- A Systematic Review of Essential Oils and the Endocannabinoid System – A Connection Worthy of Further Exploration – 2020
- Human olfactory receptors – novel cellular functions outside of the nose,” – 2017
- The diversified function and potential therapy of ectopic olfactory receptors in non-olfactory tissues – PubMed – 2017
- How does your kidney smell? Emerging roles for olfactory receptors in renal function,” – 2017
Terpenes – CB2 Receptor
- Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain – an updated review – 2021
- β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice – 2014
- The CB2 receptor and its role as a regulator of inflammation – 2016
Terpenes – Synergy with Cannabinoids:
- Taming THC – potential cannabis synergy and phytocannabinoid-terpenoid entourage effects – 2011
- A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. – PubMed – NCBI
- Entourage Effect 2.0
- Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype – 2018
- Terpenoids and Phytocannabinoids Co-Produced in Cannabis Sativa Strains Show Specific Interaction for Cell Cytotoxic Activity – 2019
- Absence of Entourage – Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors – 2019
- Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors – 2020
- The “Entourage Effect” – Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders – 2020
Terpenes – Marijuana Strains
- Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort – 2018
- Terpenoid Chemoprofiles Distinguish Drug-type Cannabis sativa L. Cultivars in Nevada – 2018
- Terpenoids and Phytocannabinoids Co-Produced in Cannabis Sativa Strains Show Specific Interaction for Cell Cytotoxic Activity – 2019
- Identification of Terpenoid Chemotypes Among High (−)-trans-Δ9- Tetrahydrocannabinol-Producing Cannabis sativa L. Cultivars 0 2017
- The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products – 2018
Terpenes – Routes of Use:
- The Effects of Essential Oils and Terpenes in Relation to Their Routes of Intake and Application – 2020
- Antiviral effect of phytochemicals from medicinal plants – Applications and drug delivery strategies – 2020
- Cannabinoid Delivery Systems for Pain and Inflammation Treatment – 2018
Terpenes – Bioavailability
- Bioavailability and Pharmacokinetics of Natural Volatile Terpenes in Animals and Humans – 2000
- Bioavailability of Bioactive Compounds
- SPC Liposomes as Possible Delivery Systems for Improving Bioavailability of the Natural Sesquiterpene β-Caryophyllene – 2018
Terpenes – Arthritis
Terpenes – Anxiety
- Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype – 2018
- The “Entourage Effect”: Terpenes Coupled With Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders – PubMed – 2019
- Medicinal cannabis for psychiatric disorders – a clinically-focused systematic review – 2020
- A Systematic Review of the Anxiolytic-Like Effects of Essential Oils in Animal Models – 2015
- A Systematic Review on the Anxiolytic Effect of Aromatherapy during the First Stage of Labor – 2019
- A Systematic Review on the Anxiolytic Effectsof Aromatherapy in People with Anxiety Symptoms – 2011
- Anxiolytic Terpenoids and Aromatherapy for Anxiety and Depression – PubMed – 2020
- Effect of Aromatherapy on Dental Anxiety Among Orthodontic Patients – A Randomized Controlled Trial – 2019
- Essential Oils and Their Constituents – An Alternative Source for Novel Antidepressants – 2017
- Essential Oils and Their Constituents Targeting the GABAergic System and Sodium Channels as Treatment of Neurological Diseases – 2018
- Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia – 2021
- The calming effect of roasted coffee aroma in patients undergoing dental procedures – 2021
- The Effect of Lavender Aroma on Anxiety of Patients Having Bone Marrow Biopsy- 2020
- The-Effects-of-Essential-Oils-and-Terpenes-in-Relation-to-Their-Routes-of-Intake-and-Application-2020
- Therapeutic Effect and Mechanisms of Essential Oils in Mood Disorders – Interaction between the Nervous and Respiratory Systems – 2021
- Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats – 2019
Terpenes – Infectious Diseases
- Phytochemical Analysis and in vitro Antiviral Activities of the Essential Oils of Seven Lebanon Species – 2008
- Antiviral effect of phytochemicals from medicinal plants – Applications and drug delivery strategies – 2020
- Essential Oils and Coronaviruses – 2020
Terpenes – Pain:
- Analgesic-like Activity of Essential Oils Constituents – 2011
- Analgesic-Like Activity of Essential Oil Constituents – An Update – 2017
- Medicinal Plants of the Family Lamiaceae in Pain Therapy – A Review – 2018
- Analgesic Potential of Essential Oils – 2016
- Medicinal Plants of the Family Lamiaceae in Pain Therapy – A Review – 2018
- Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort – 2018
- Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant – 2020
- The Molecular Mechanisms That Underpin the Biological Benefits of Full-Spectrum Cannabis Extract in the Treatment of Neuropathic Pain and Inflammation – PubMed – 2020
- Cannabis-based medicines and the perioperative physician – 2019
- Cannabis‐based medicines for chronic neuropathic pain in adults – 2018
- Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain – An Update on Current Evidence and Cannabis Science – 2018
- Role of Cannabinoids and Terpenes in Cannabis-Mediated Analgesia in Rats – PubMed – 2019
- Antinociceptive effect of inhalation of the essential oil of bergamot in mice – 2018
- Analgesic Potential of Essential Oils – 2016
- Analgesic-Like Activity of Essential Oil Constituents – An Update – 2017
Terpenes – Headaches:
- Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain – An Update on Current Evidence and Cannabis Science – 2018
- Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort – 2018
Terpenes – Inflammation:
- Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. – 2015
- Cannabis sativa L. and Nonpsychoactive Cannabinoids – Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer – 2018
- Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort – 2018
- Therapeutic Potential of Volatile Terpenes and Terpenoids from Forests for Inflammatory Diseases – 2020
- The Molecular Mechanisms That Underpin the Biological Benefits of Full-Spectrum Cannabis Extract in the Treatment of Neuropathic Pain and Inflammation – PubMed – 2020
- Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. – 2015
- Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease? – 2019
- Therapeutic Applications of Terpenes on Inflammatory Diseases – 2021
Terpenes – Wound Healing:
Individual Sources of Terpenes
Terpenes – Bergamot
- The Anxiolytic Effect of Aromatherapy on Patients Awaiting Ambulatory Surgery – A Randomized Controlled Trial – 2013
- Antinociceptive effect of inhalation of the essential oil of bergamot in mice – 2018
- Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats – 2019
- Bergamot – Natural Medicines – Professional.pdf
- Citrus bergamia essential oil – from basic research to clinical application – 2015
- Role of 5-HT1A Receptor in the Anxiolytic-Relaxant Effects of Bergamot Essential Oil in Rodent – 2020 Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs – PubMed – 2019
- Possible involvement of the peripheral Mu-opioid system in antinociception induced by bergamot essential oil to allodynia after peripheral nerve injury – PubMed – 2018
- Peripherally injected linalool and bergamot essential oil attenuate mechanical allodynia via inhibiting spinal ERK phosphorylation – PubMed – 2013
- Neuropharmacology of the essential oil of bergamot – PubMed – 2010
- Effect of Harvesting Time on Volatile Compounds Composition of Bergamot (Citrus × Bergamia) Essential Oil – 2019
- Chemical Composition and Biological Activities of Essential Oils from Peels of Three Citrus Species – 2020
- Chemical_Composition_of_Bergamot_Citrus_Bergamia_Risso_Essential_Oil_Obtained_by_Hydrodistillation – 2010
- Cannabinoid Signaling in the Skin – Therapeutic Potential of the “C(ut)annabinoid” System – 2019
- Rational Basis for the Use of Bergamot Essential Oil in Complementary Medicine to Treat Chronic Pain – PubMed – 2016
Terpenes – Lavender Oil
Individual Terpenes
Terpenes: β-Caryophyllene:
- (−)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis – 2017
- Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice. – PubMed – NCBI
- Acute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion – 2018
- Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice. – PubMed – NCBI
- Cannabimimetic phytochemicals in the diet – an evolutionary link to food selection and metabolic stress adaptation? – 2016
- The anxiolytic-like effect of an essential oil derived from Spiranthera odoratissima A. St. Hil. leaves and its major component, β-caryophyllene, in male mice – 2012
- β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties – 2016
- β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice – 2014
- Toxicological Evaluation of β-Caryophyllene Oil: Subchronic Toxicity in Rats. – PubMed – NCBI 2016
- The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic… – PubMed – NCBI – 2014
- The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain – 2013
- SPC Liposomes as Possible Delivery Systems for Improving Bioavailability of the Natural Sesquiterpene β-Caryophyllene – 2018
- β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway – 2011
- Why wild giant pandas frequently roll in horse manure – 2020
- Beta-caryophyllene is a dietary cannabinoid – 2008
- Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. – 2006
- The menthol receptor TRPM8 is the principal detector of environmental cold – PubMed – 2007
- Molecular basis of peripheral innocuous cold sensitivity – 2018
- Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception – PubMed – 2013
- NON-CANNABIS THERAPY – Cannabinoid Therapy Without Using Cannabis: Direct Effects™ Topical β-Caryophyllene
Terpenes: Linalool:
- GS12-linalool
- Linalool – 1997
- The “Entourage Effect”: Terpenes Coupled With Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders – PubMed – 2020
- An olfactory stimulus modifies nighttime sleep in young men and women. – PubMed – NCBI
- Lavender and sleep – A systematic review of the evidence – 2012
- Lavender and the Nervous System – 2013
- Effects of odorant administration on objective and subjective measures of sleep quality, post-sleep mood and alertness, and cognitive performance – 2003
- In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes. – PubMed – NCBI – 2000
- Odors enhance slow-wave activity in non-rapid eye movement sleep – 2016
- A question of scent – lavender aroma promotes interpersonal trust – 2015
- Is Lavender an Anxiolytic Drug? A Systematic Review of Randomised Clinical Trials – 2012
- Efficacy of Silexan in subthreshold anxiety – meta-analysis of randomised, placebo-controlled trials – 2019
- Essential oil of lavender in anxiety disorders – Ready for prime time? – 2017
- Linalool is a PPAR ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome – 2014
- A Review of the Potential Use of Pinene and Linalool as Terpene-Based Medicines for Brain Health – Discovering Novel Therapeutics in the Flavours and Fragrances of Cannabis – 2021
- The Efficacy of Lavender Aromatherapy in Reducing Preoperative Anxiety in Ambulatory Surgery Patients Undergoing Procedures in General Otolaryngology – 2017
- Efficacy, Safety and Tolerability of Aroma Massage with Lavender Essential Oil – an Overview – 2020
- Antinociceptive and anticonvulsant effects of the monoterpene linalool oxide – 2017
- Exploring Pharmacological Mechanisms of Lavender (Lavandula angustifolia) Essential Oil on Central Nervous System Targets – 2017
- Linalool Ameliorates Memory Loss and Behavioral Impairment Induced by REM-Sleep Deprivation through the Serotonergic Pathway – 2018
- Effects of lavender on anxiety, depression and physiologic parameters – Systematic Review and Meta-Analysis – 2021
- Lavender and sleep – A systematic review of the evidence – 2012
- Lavender and the Nervous System – 2013
- A question of scent – lavender aroma promotes interpersonal trust – 2015
Terpenes, Linalool: – Silexan
- A Multi-Center, Double-Blind, Randomised Study of the Lavender Oil Preparation Silexan in Comparison to Lorazepam for Generalized Anxiety Disorder – 2010
- Is Lavender an Anxiolytic Drug? A Systematic Review of Randomised Clinical Trials – 2012
- An Orally Administered Lavandula Oil Preparation (Silexan) for Anxiety Disorder and Related Conditions- An Evidence Based Review – 2013
- Lavender oil preparation Silexan is effective in generalized anxiety disorder – a randomized, double-blind comparison to placebo and paroxetine – 2014
- Silexan in anxiety disorders – Clinical data and pharmacological background – 2017
- Effectiveness of Silexan Oral Lavender Essential Oil Compared to Inhaled Lavender Essential Oil Aromatherapy for Sleep in Adults- A Systematic Review – 2018
- Silexan in anxiety disorders Clinical data and pharmacological background – PubMed – 2018
- Efficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders – A network meta-analysis – 2019
- Efficacy of Silexan in subthreshold anxiety – meta-analysis of randomised, placebo-controlled trials – 2019
- Therapeutic effects of Silexan on somatic symptoms and physical health in patients with anxiety disorders – A meta- analysis – 2020
- Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder a randomized, double-blind, placebo controlled trial – PubMed – 2010
- A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder – PubMed – 2009
- No Abuse Potential of Silexan in Healthy Recreational Drug Users – A Randomized Controlled Trial – 2021
Terpenes – Limonene
- Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. – 2015
- Neuroprotective Potential of Limonene and Limonene Containing Natural Products – 2021
Terpenes: Myrcene
- β-MYRCENE – IARC MONOGRAPHS
- Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. – 2015
Terpenes: Pinene
Emphasis on Education
Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.
For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.
Should you wish more information regarding any of the subjects listed – or not listed – here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.
For more information, please contact Accurate Clinic.
Supplements recommended by Dr. Ehlenberger may be purchased commercially online or at Accurate Clinic.
Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.
Accurate Supplement Prices